The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis
Open accessAbstract
Objectives The study evaluates the clinical course and the development of systolic and diastolic left ventricular function in patients with chronic myocarditis with or without autoantibodies against cardiac myosin. Background Patients with myocarditis often show autoantibodies against cardiac myosin. The clinical and pathophysiologic significance of these antimyosin autoantibodies (AMAAB) is yet unknown. The results from studies comparing the clinical course and the development of left ventricular function in patients with chronic myocarditis with or without AMAAB are not yet available. Methods Thirty-three patients with biopsy proven chronic myocarditis underwent analysis of AMAAB, right and left heart catheterization and left ventriculography at baseline and after six months. Left ventricular volumes and ejection fraction as well as the time constant of left ventricular relaxation "tau" and the constant of myocardial stiffness "b" were determined at baseline and at follow-up. Results In 17 (52%) patients, AMAAB could be detected at baseline. After six months, AMAAB were still found in 13 (76%) initially antibody-positive patients. No initially antibody-negative (n = 16) patient developed AMAAB during follow-up. Clinical symptoms improved slightly in antibody-negative patients and remained stable in antibody-positive patients. Left ventricular ejection fraction developed significantly better in antibody-negative patients (+8.9 +/- 10.1%) compared with antibody-positive patients (-0.1 +/- 9.4%) (p < 0.012). Stroke volume (SV) and stroke volume index (SVI) also improved in antibody-negative patients (SV: +20 +/- 31 ml; SVI: +10 +/- 17 ml) compared with antibody-positive patients (SV: -14 +/- 43 ml; SVI: -8 +/- 22 ml) (SV: p < 0.015; SVI: p < 0.016). Left ventricular end-diastolic and end-systolic volumes and the time constant of left ventricular relaxation "tau" did not change significantly different in antibody-positive and antibody-negative patients. The constant of myocardial stiffness "b" improved significantly in antibody-negative patients (-6.1 +/- 10.8) compared with antibody-positive patients (+7.3 +/- 22.6) (p < 0.040). Analyzing only the persistently antibody-positive patients yielded essentially the same results. Conclusions Antimyosin autoantibodies are associated with worse development of left ventricular systolic function and diastolic stiffness in patients with chronic myocarditis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some patients with myocarditis showed a correlation between antimyosin antibody titer and the severity of cardiac dysfunction, whereas in others, the titer became undetectable”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [86]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“an elevated level of antimyosin autoantibodies in the serum of both myocarditis patients and murine models, as well as in other cardiovascular disease conditions”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [86]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myocarditis. A histopathologic definition and classification.
Aretz, H. T., Billingham, M. E., Edwards, W. D., Factor, S. M., Fallon, J. T., Fenoglio, J. J., Olsen, E. G. J., & Schöen, F. J. (1987) · PubMed · Cited by 1,307
Idiopathic Dilated Cardiomyopathy
Dec, G. W., & Fuster, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312307 · Cited by 957
A new protein of the thick filaments of vertebrate skeletal myofibrils
Offer, G., Moos, C., & Starr, R. (1973) · Journal of Molecular Biology · doi:10.1016/0022-2836(73)90055-7 · Cited by 629
Usefulness and limitations of radiographic methods for determining left ventricular volume
Dodge, H. T., Sandler, H., Baxley, W. A., & Hawley, R. R. (1966) · The American Journal of Cardiology · doi:10.1016/0002-9149(66)90191-3 · Cited by 613
Bowles, N. E., Olsen, E. G. J., Richardson, P. J., & ARCHARD, L. C. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91837-4 · Cited by 601
Myosin isoenzyme redistribution in chronic heart overload
Lompré, A., Schwartz, K., d’Albis, A., Lacombe, G., Thiem, N. V., & Bernard Swynghedauw, A. (1979) · Nature · doi:10.1038/282105a0 · Cited by 523
Cardiac myosin induces myocarditis in genetically predisposed mice.
Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G., & Craig, S. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3630 · Cited by 523
Raff, G. L., & Glantz, S. A. (1981) · Circulation Research · doi:10.1161/01.res.48.6.813 · Cited by 444
HAUCK, A. J., Kearney, D. L., & Edwards, W. D. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61286-5 · Cited by 436
Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis
Chow, L. H., Radio, S. J., Sears, T. D., & McManus, B. M. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90465-8 · Cited by 353
Research works printed but not linked: 4
- Aretz, 1987, Myocarditis, Am J Cardiovasc Pathol, 1, 3
- Kühl, 1992, Dilative Kardiomyopathie-eine chronische Myokarditis? Immunhistologische Charakterisierung lymphozytärer Zellen, Herz, 17, 97
- Morimoto, 1992, Clinical and pathologic features of chronic myocarditis, Am J Cardiovasc Pathol, 4, 181
- Neu, 1987, Coxsackie virus induced myocarditis in mice, Clin Exp Immunol, 69, 566
Cited by
Sorted by citations
Items 101–197 of 197
Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans
Lim, B., Ju, E., Lao, D. H., Yun, S., Lee, Y., Kim, D., & Jeon, E. (2013) · Microbiology and Immunology · doi:10.1111/1348-0421.12028 · Cited by 15
Kreidieh, F., & McQuade, J. L. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100374 · Cited by 14
Detection of antibodies in cardiac autoimmunity
Wehlou, C., & Delanghe, J. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.08.002 · Cited by 14
JAK-STAT Signaling Circuits in Myocarditis and Dilated Cardiomyopathy*
Ruppert, V., & Meyer, T. (2007) · Herz · doi:10.1007/s00059-007-3040-x · Cited by 13
George, J., Barshack, I., Malka, E., Goldberg, I., Keren, P., Laniado, S., & Keren, G. (2001) · Experimental and Molecular Pathology · doi:10.1006/exmp.2001.2382 · Cited by 13
Maier, R., Miller, S., Kurrer, M. O., Krebs, P., de Giuli, R., Kremer, M., Scandella, E., & Ludewig, B. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.06.013 · Cited by 12
Błyszczuk, P., Valaperti, A., & Eriksson, U. (2008) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x10808040313 · Cited by 12
Viral Infection and Heart Disease: Autoimmune Mechanisms
Afanasyeva, M., & Rose, N. R. (2004) · Elsevier eBooks · doi:10.1016/b978-044451271-0.50025-9 · Cited by 12
Cardiomyopathy Is Linked to Complement Activation
Afanasyeva, M., & Rose, N. R. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64189-2 · Cited by 12
Immune mediators in inflammatory heart disease: insights from a mouse model
Afanasyeva, M. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90107-0 · Cited by 12
Knowlton, K. U., & Lim, B. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.035 · Cited by 12
Won, T., Kalinoski, H. M., Wood, M. K., Hughes, D. M., Jaime, C. M., Talor, M. V., Lasrado, N., Reddy, J., & Čiháková, D. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4065075 · Cited by 12
Cellular Immunology of Myocarditis: Lights and Shades—A Literature Review
Vicenzetto, C., Giordani, A. S., Menghi, C., Baritussio, A., Scognamiglio, F., Pontara, E., Bison, E., Cattini, M. G., Marcolongo, R., & Caforio, A. L. P. (2024) · Cells · doi:10.3390/cells13242082 · Cited by 12
Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies
Tang, W. H. W., & Prasad, S. V. N. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001264 · Cited by 10
Clinical Implications of Anti-cardiac Immunity in Dilated Cardiomyopathy
Caforio, A. L. P., Mahon, N., & McKenna, W. J. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_11 · Cited by 10
Dilated cardiomyopathy (DCM) and myocarditis: Classification, clinical and autoimmune features
Caforio, A. L. P., Bottaro, S., & Iliceto, I. (2012) · Cited by 10
Modulation of TLR4/NFκB Pathways in Autoimmune Myocarditis
Interdonato, L., Impellizzeri, D., D’Amico, R., Cordaro, M., Siracusa, R., D’Agostino, M., Genovese, T., Gugliandolo, E., Crupi, R., Fusco, R., et al. (2023) · Antioxidants · doi:10.3390/antiox12081507 · Cited by 9
O’Donohoe, T. J., Schrale, R. G., Sıkder, S., Surve, N. Z., Rudd, D., & Ketheesan, N. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.03.008 · Cited by 9
Therapeutic Advances in Emergency Cardiology: A Focus on Acute Myocarditis
Crișan, S., Ţînţ, D., & Petrescu, L. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000921 · Cited by 9
Halapas, A., Pissimissis, N., Lembessis, P., Rizos, I. K., Rigopoulos, A. A., Kremastinos, D., & Koutsilieris, M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.7.821 · Cited by 9
Atorvastatin Attenuates Coxsackie Virus B3m-induced Viral Myocarditis in Mice
Guan, J., Sun, X., Liang, Y., Dong, W., Zhang, L., Zhu, J., & Wang, G. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181f6b28d · Cited by 9
Staudt, Y., Trimpert, C., Birkenmeier, K., Krieg, T., Bemmann, T., Beug, D., Felix, S. B., & Staudt, A. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01603.x · Cited by 9
2025 Clinical practice guidelines for Myocarditises
Arutyunov, G. P., Драгунов, Д. О., Жиров, И. В., Моисеева, О. М., Палеев, Ф. Н., Sokolova, A. V., Apkhanova, T. V., Arutyunov, A. G., Blagova, O. V., Габрусенко, С. А., et al. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6458 · Cited by 10
Weinmann, K., Werner, J., Köenig, W., Rottbauer, W., Walcher, D., & Keßler, M. (2018) · Biomolecules · doi:10.3390/biom8040133 · Cited by 8
Novel therapeutic options in inflammatory cardiomyopathy
Kania, G., Błyszczuk, P., Müller‐Edenborn, B., & Eriksson, U. (2013) · Swiss Medical Weekly · doi:10.4414/smw.2013.13841 · Cited by 9
Autoinmunidad y miocardiopatía dilatada: situación actual y perspectivas
Martín, M. A. S., García, Á., Rodríguez, F. J., & Terol, I. (2002) · Revista Española de Cardiología · doi:10.1016/s0300-8932(02)76644-x · Cited by 8
Çavuşoğlu, Y., Tahmazov, S., Murat, S., & Akay, O. M. (2023) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20220784 · Cited by 7
Associations Between TIM1 Polymorphisms and Dilated Cardiomyopathy in a Han Chinese Population
Xie, X., Li, C., Zhou, B., Dai, X., & Rao, L. (2016) · International Heart Journal · doi:10.1536/ihj.16-119 · Cited by 7
Sporter, R. J., Kim, J., & Frishman, W. H. (2008) · Cardiology in Review · doi:10.1097/crd.0b013e318188591c · Cited by 7
Zhao, L., Li, S., Ge, J., Sun, A., Zou, Y., & Zhang, S. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.10.005 · Cited by 7
Winkel, E., & Parrillo, J. E. (2002) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-002-0040-2 · Cited by 7
Role of T Cells in Viral and Immune-mediated Myocarditis
Cheng, C., Baritussio, A., Giordani, A. S., Marcolongo, R., Caforio, A. L. P., & Iliceto, S. (2024) · Cardiology Discovery · doi:10.1097/cd9.0000000000000116 · Cited by 6
Immunadsorption als Therapieverfahren der dilatativen Kardiomyopathie
Felix, S. B., Dörr, M., Herda, L. R., Beug, D., & Staudt, A. (2007) · Der Internist · doi:10.1007/s00108-007-1991-x · Cited by 6
Vigne, J., Cognet, T., Guedj, K., Morvan, M., Merceron, O., Louedec, L., Choqueux, C., Nicoletti, A., Escoubet, B., Chaubet, F., et al. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01420-8 · Cited by 6
Miyamoto, S. D., Brown, R. D., Robinson, B. A., Tyler, K. L., Long, C. S., & DeBiasi, R. L. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.004 · Cited by 6
Can Serum Tenascin-C Be Used as a Marker of Inflammation in Patients with Dilated Cardiomyopathy?
Kotby, A., Aziz, M. M. A., Elguindy, W. M., & Moneer, A. N. (2013) · International Journal of Pediatrics · doi:10.1155/2013/608563 · Cited by 6
Kaski, J. P., & Elliot, P. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-3064-2.00052-7 · Cited by 5
Mason, J. W., Trehan, S., & Renlund, D. G. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_62 · Cited by 7
Autoimmune Myocarditis: Animal Models
Poli, V., Bruno, K. A., & Fairweather, D. (2020) · Myocarditis · doi:10.1007/978-3-030-35276-9_6 · Cited by 5
Winkel, E., Costanzo, M. R., & Parrillo, J. E. (2000) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-000-0036-8 · Cited by 5
Rose, N. R., & Čiháková, D. (2004) · Autoimmunity · doi:10.1080/08916930410001705457 · Cited by 5
Tissot, C., da Cruz, E. M., & Miyamoto, S. D. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4619-3_229 · Cited by 4
Clinical Presentation of Myocarditis
Caforio, A. L. P., Marcolongo, R., Cheng, C., Baritussio, A., Tarantini, G., & Iliceto, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_2 · Cited by 4
Myokarditis: Diagnostik und Verlauf
(2004) · Kardiovask Med · doi:10.4414/cvm.2004.01035 · Cited by 4
Crosio, S., Treglia, G., Imbimbo, M., Froesch, P., Gauthier, L. G., Arangalage, D., Bergamaschi, L., Györik, S., Viani, G. M., Caretta, A., et al. (2025) · Echocardiography · doi:10.1111/echo.70115 · Cited by 3
Pathogenic drivers of lupus myocarditis and potential therapeutic targets
Liu, Y., Murphy, K. M., Hung, Y. F., & Won, T. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01580-4 · Cited by 3
Immunoadsorption in patients with dilated cardiomyopathy
Herda, L. R., Felix, S. B., & Staudt, A. (2009) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(09)71826-4 · Cited by 3
Novel Pathogenetic Mechanisms in Myocarditis: Nitric Oxide Signaling
Kittleson, M. M., Lowenstein, C. J., & Hare, J. M. (2005) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.06.002 · Cited by 3
Myocardites aiguës et subaiguës
Bouhour, J.-B., & Heymann, M. (2006) · EMC - Cardiologie · doi:10.1016/s1166-4568(01)00062-6 · Cited by 3
Organ-Specific Autoimmune Myocardial Diseases
Caforio, A. L. P., Marcolongo, R., Malipiero, G., Agostini, C., Seguso, M., Gallo, N., Plebani, M., & Iliceto, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803267-1.00002-8 · Cited by 3
Humoral Immune Response in Viral Myocarditis
Maisch, B., & Ristić, A. D. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-319-4_4 · Cited by 3
Felix, S. B. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0140-1 · Cited by 3
Menghi, C., Giordani, A. S., Baritussio, A., Scognamiglio, F., Vicenzetto, C., Peloso-Cattini, G., Pontara, E., Bison, E., Basso, C., Marcolongo, R., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.134087 · Cited by 2
Inflammatory Diseases of the Heart and Pericardium: Dilated Cardiomyopathy and Myocarditis
Wiles, H. B., Kooy, N. W., & Wheeler, D. S. (2008) · Springer eBooks · doi:10.1007/978-1-84800-923-3_21 · Cited by 2
Dec, G. W. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_2 · Cited by 2
Acute Myocarditis in Emergency Medicine
Ikegami, Y., & Tase, C. (2011) · InTech eBooks · doi:10.5772/21760 · Cited by 2
Weikert, U., Rauch, U., Kühl, U., Hohmann, C., Jaster, M., Pauschinger, M., Schwimmbeck, P. L., & Schultheiß, H. (2002) · Zeitschrift für Kardiologie · doi:10.1007/s00392-002-0770-x · Cited by 2
Self-citationAcute idiopathic pericarditis: current immunological theories
Caforio, A. L. P., Marcolongo, Brucato, Cantarini, Imazio, & Iliceto (2012) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s20463 · Cited by 2
Sheng, C.-Q., Zhang, Z., Jia, Y., & Li, Y. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.10.904 · Cited by 2
A Novel Strategy for Etiologic Factor Removal: Drug-Navigated Clearance System (DNCS)
Mahara, A., Harada‐Shiba, M., & Yamaoka, T. (2017) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00282 · Cited by 2
Immunomodulation and Immunoadsorption in Inflammatory Dilated Cardiomyopathy
Chamling, B., Könemann, S., Dörr, M., & Felix, S. B. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_15 · Cited by 2
Foreword to special issue on “Myocarditis”
Caforio, A. L. P. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9413-8 · Cited by 2
Albakri, A. (2019) · Medical and Clinical Archives · doi:10.15761/mca.1000154 · Cited by 1
Al‐Mohaissen, M. A., Lee, T., & Qattea, M. B. (2025) · CJC Open · doi:10.1016/j.cjco.2025.08.009 · Cited by 1
Organ-Specific Autoimmunity Involvement in Cardiovascular Disease
Caforio, A. L. P., Tona, F., & McKenna, W. J. (2003) · Technical report · doi:10.1016/s1571-5078(03)01002-x · Cited by 1
Rajčáni, J. (2015) · Medical Research Archives · doi:10.18103/mra.v2i1.330 · Cited by 1
Caforio, A. L. P., & McKenna, W. J. (2003) · Developments in cardiovascular medicine · doi:10.1007/978-1-4419-9264-2_9 · Cited by 1
Fairweather, D., Afanasyeva, M., & Rose, N. R. (2017) · Technical report · doi:10.1016/b978-0-12-803997-7.00001-6 · Cited by 1
Organ-Specific Autoimmunity Involvement in Cardiovascular Disease
Caforio, A. L. P., Malipiero, G., Marcolongo, R., & Iliceto, S. (2017) · Technical report · doi:10.1016/b978-0-12-803997-7.00002-8 · Cited by 1
Models of autoimmune heart disease
Eriksson, U., Köpf, M., Afanasyeva, M., & Penninger, J. M. (2004) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2004.11.015 · Cited by 1
Diastolic Function and Dysfunction
Bronicki, R. A., & Penny, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-63557-1_3 · Cited by 1
Pathogenic relevance of autoantibodies in dilated cardiomyopathy
Jahns, R., Boivin, V., Ertl, G., & Lohse, M. J. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_7
Immunoadsorption in dilated cardiomyopathy patients
Felix, S. B., & Staudt, A. (2010) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8352-7_15
Inflammation and Infection in Coronary Artery Disease
Lauer, M. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-096-6_3
Patogénesis molecular en un modelo experimental de miocarditis
Cifuente, J. O. (2009) · doi:10.35537/10915/27710
Heart Failure—Role of Autoimmunity
Eriksson, U. (2007) · Wiley eBooks · doi:10.1002/9780470692325.ch3
第13回 頻拍症カンファランス 心筋症における抗心筋自己抗体の病態生理学的意義
勉, 吉. (2005) · 心臓 · doi:10.11281/shinzo1969.37.10_880
Infective and Infiltrative Cardiomyopathies
Kounas, S. P., & Elliot, P. M. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch50
Sanad, W. (2008) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10653
Therapy for pediatric myocarditis
Canter, C. E. (2005) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-005-0025-z
La inmunoadsorción: ¿alternativa o adyuvante del tratamiento quirúrgico?
Ayuso‐Mateos, J. L., Fernandez-Divar, J. A., & Herreros, J. M. (2011) · Cirugía Cardiovascular · doi:10.1016/s1134-0096(11)70066-3
Anti‐inflammatory role of obestatin in autoimmune myocarditis
Pamukçu, Ö., Baykan, A., Bayram, L. Ç., Narin, F., Çetin, N., Narın, N., Argun, M., Özyurt, A., & Üzüm, K. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12497
Staab, L. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13178
Immune System Alterations in Acute Heart Failure
Adams, K. F., & Ng, T. M. H. (2008) · Springer eBooks · doi:10.1007/978-1-84628-782-4_14
Development of enterovirus diagnostic assay system for human patients
Lim, B., Ju, E., Lao, D. H., Yun, S., Lee, Y., Kim, D., & Jeon, E. (2013) · Microbiology and Immunology · doi:10.1111/j.1348-0421.12028
Organ-Specific Autoimmune Myocarditis
Caforio, A. L. P., Cheng, C., Seguso, M., Gallo, N., Marcolongo, R., & Iliceto, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-35276-9_10
Tissot, C., da Cruz, E. M., & Miyamoto, S. D. (2009) · Springer eBooks · doi:10.1007/978-1-84882-262-7_49
Nakano, S. J., da Cruz, E. M., Tissot, C., & Miyamoto, S. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-21870-6_47
Goldman, M. E. (2001) · doi:10.1007/978-1-4615-6601-4_28
Canter, C. E., & Simpson, K. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802393-8.00016-8
Follow-Up and Long-Term Prognosis of Myocarditis and Fulminant Myocarditis
Jiang, J., & Wang, D. W. (2022) · Springer eBooks · doi:10.1007/978-981-19-5759-8_19
Myers, J. M., Sandel, C., Alvarez, K. M., Garman, L., Wiley, G. B., Montgomery, C. G., Gaffney, P. M., Stavrakis, S., Fairweather, D., Bruno, K. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.19.599804
Simpson, K. E., Jone, P., Orr, W. B., & Canter, C. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13279-7.00032-8
Cardioprotective Effect of Metformin Treatment in Mouse Model of Experimental Autoimmune Myocarditis
Czepiec, M., Fryt, K., Jaźwa, A., Laimbacher, A., Kania, G., Siedlar, M., Tyszka‐Czochara, M., & Błyszczuk, P. (2026) · Cardiovascular Therapeutics · doi:10.1155/cdr/6615227
Maisch, B., Ristić, A. D., Herzum, M., Hufnagel, G., & Pankuweit, S. (2001) · Steinkopff eBooks · doi:10.1007/978-3-642-93722-4_2
Clinical Diagnosis of Myocarditis
Dec, G. W. (2003) · Developments in cardiovascular medicine · doi:10.1007/978-1-4419-9264-2_28
Metadata
- Authors
- Lauer, B., Schannwell, M., Kühl, U., Strauer, B.-E., & Schultheiss, H.-P.
- Affiliations
- Leipzig University (DE)
- Heinrich Heine University Düsseldorf (DE)
- Corresponding author
- Lauer, Bernward
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2000-01
- Volume
- 35
- Issue
- 1
- Pages
- 11-18
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2078336460
- Cited by
- 197
- References
- 55
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 6 · 2021: 3 · 2020: 7 · 2019: 7 · 2018: 4 · 2017: 9 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 11 · 2012: 6
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Takotsubo Cardiomyopathy and Associated Phenomena
- Keywords
- chronic myocarditis, left ventricular function, systolic function, diastolic function, left ventricular ejection fraction, myocardial stiffness, left ventricular relaxation, stroke volume, autoantibody persistence, left ventriculography, cardiac catheterization, left ventricular volume
- MeSH terms
- Adult, Aged, Autoantibodies, Autoimmune Diseases, Biopsy, Chronic Disease, Diastole, Endocardium, Female, Humans, Male, Middle Aged, Myocardial Contraction, Myocarditis, Myosins, Stroke Volume, Systole, Ventricular Function, Left, Ventricular Dysfunction, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
